Literature DB >> 30642643

Effect of statins on atherosclerotic plaque.

Shone O Almeida1, Matthew Budoff2.   

Abstract

Lipid lowering therapy has been the mainstay of cardiovascular risk reduction and prevention. Statin drugs have been shown to reduce serum cholesterol along with significant reduction in morbidity and mortality of cardiovascular disease. Whether these benefits are purely through lipid lowering or pleiotropic (cholesterol independent) effects has yet to be fully understood. Advances in cardiac imaging, from intravascular ultrasound to multi-detector coronary computed tomography angiography, have furthered our understanding of statin's effect on atherosclerotic plaque. Notably, statins play a role in plaque regression with reduction in lipid content. These drugs further stabilize atherosclerotic plaque with thickened fibrous caps and macrocalcification that serves to stabilize atheromas.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30642643     DOI: 10.1016/j.tcm.2019.01.001

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  28 in total

1.  Preventive effects of ginseng against atherosclerosis and subsequent ischemic stroke: A randomized controlled trial (PEGASUS trial).

Authors:  Boseong Kwon; Yunsun Song; Joong-Goo Kim; Dongwhane Lee; Sang-Hun Lee; Young-Keol Cho; Jong S Kim; Dae Chul Suh
Journal:  J Ginseng Res       Date:  2021-11-11       Impact factor: 5.735

Review 2.  Prevention of Anthracycline-Induced Cardiotoxicity: The Good and Bad of Current and Alternative Therapies.

Authors:  Nonhlakanipho F Sangweni; Derick van Vuuren; Lawrence Mabasa; Kwazi Gabuza; Barbara Huisamen; Sharnay Naidoo; Reenen Barry; Rabia Johnson
Journal:  Front Cardiovasc Med       Date:  2022-06-22

Review 3.  Obesity and Pancreatic Cancer: Recent Progress in Epidemiology, Mechanisms and Bariatric Surgery.

Authors:  Shuhei Shinoda; Naohiko Nakamura; Brett Roach; David A Bernlohr; Sayeed Ikramuddin; Masato Yamamoto
Journal:  Biomedicines       Date:  2022-05-31

Review 4.  Emerging views of statin pleiotropy and cholesterol lowering.

Authors:  Dongbo Yu; James K Liao
Journal:  Cardiovasc Res       Date:  2022-01-29       Impact factor: 10.787

5.  Combined effects of carotid plaques and hypertension on the risk of cardiovascular disease and all-cause mortality.

Authors:  Wen Li; Jianqiu Zhao; Lu Song; Shuohua Chen; Xuemei Liu; Shouling Wu
Journal:  Clin Cardiol       Date:  2020-05-12       Impact factor: 2.882

6.  Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel.

Authors:  Jan Borén; M John Chapman; Ronald M Krauss; Chris J Packard; Jacob F Bentzon; Christoph J Binder; Mat J Daemen; Linda L Demer; Robert A Hegele; Stephen J Nicholls; Børge G Nordestgaard; Gerald F Watts; Eric Bruckert; Sergio Fazio; Brian A Ference; Ian Graham; Jay D Horton; Ulf Landmesser; Ulrich Laufs; Luis Masana; Gerard Pasterkamp; Frederick J Raal; Kausik K Ray; Heribert Schunkert; Marja-Riitta Taskinen; Bart van de Sluis; Olov Wiklund; Lale Tokgozoglu; Alberico L Catapano; Henry N Ginsberg
Journal:  Eur Heart J       Date:  2020-06-21       Impact factor: 29.983

7.  Plasma Metabolic Signature of Atherosclerosis Progression and Colchicine Treatment in Rabbits.

Authors:  Mario Augusto Izidoro; Alberto Cecconi; María Isabel Panadero; Jesús Mateo; Joanna Godzien; Jean Paul Vilchez; Ángeles López-Gonzálvez; Jesús Ruiz-Cabello; Borja Ibañez; Coral Barbas; Francisco J Rupérez
Journal:  Sci Rep       Date:  2020-04-27       Impact factor: 4.379

8.  Resveratrol for protection against statin toxicity in C2C12 and H9c2 cells.

Authors:  Chama Attalah Nee Rezkallah; Angkana Thongkum; Chao Zhu; Qin M Chen
Journal:  J Biochem Mol Toxicol       Date:  2020-03-20       Impact factor: 3.642

9.  Effect of 2 Different Dosages of Rosuvastatin on Prognosis of Acute Myocardial Infarction Patients with New-Onset Atrial Fibrillation in Jinan, China.

Authors:  Jie Zhang; Ruiqi Feng; Misbahul Ferdous; Bo Dong; Haitao Yuan; Peng Zhao
Journal:  Med Sci Monit       Date:  2020-08-12

10.  Zebrafish Model for Screening Antiatherosclerosis Drugs.

Authors:  Jichun Han; Rui Zhang; Xiaofeng Zhang; Jing Dong; Minghan Chen; Yumin Pan; Zixian Liao; Min Zhong; Jingwen He; Feiqiang Wang; Yunyun Yue; Jing Shang
Journal:  Oxid Med Cell Longev       Date:  2021-06-22       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.